Showing results (121-130 of 291) with videos related to
Sort By:
Pageof 30
Lancet (London, England)|July 18, 1992
Protein processing in lysosomes: the new therapeutic target in neurodegenerative diseaseR J Mayer, M Landon, L Laszlo, et al.The Journal of Peptide Research : Official Journal of the American Peptide Society|July 17, 1999
Selective isopeptide bond formation: coupling ubiquitin(67-76) with histone 2A(114-128) by use of the transfer active ester condensation techniqueP Wang, R Layfield, M Landon, et al.FEBS Letters|February 26, 1990
Ubiquitinated protein conjugates are specifically enriched in the lysosomal system of fibroblastsL Laszlo, F J Doherty, N U Osborn, et al.Biochimica Et Biophysica Acta|June 13, 1991
Ubiquitin in health and diseaseR J Mayer, J Arnold, L László, et al.Progress in Clinical and Biological Research|January 1, 1989
Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseasesR J Mayer, J Lowe, G Lennox, et al.Cancer|September 1, 1978
Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancerR J Mayer, M B Garnick, G D Steele, et al.Journal of Clinical Epidemiology|June 23, 1998
Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)M T Niu, P Rhodes, M Salive, et al.The New England Journal of Medicine|November 3, 1983
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU)J D Boice, M H Greene, J Y Killen, et al.Controlled Clinical Trials|April 1, 1990
Issues in the design of drug trials for AIDSS B Green, S S Ellenberg, D Finkelstein, et al.Journal of Cellular Biochemistry|January 1, 1985
Site-specific mutagenesis of dihydrofolate reductase from Escherichia coliJ T Chen, R J Mayer, C A Fierke, et al.Pageof 30